592 related articles for article (PubMed ID: 30003031)
1. Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET.
Nedelska Z; Senjem ML; Przybelski SA; Lesnick TG; Lowe VJ; Boeve BF; Arani A; Vemuri P; Graff-Radford J; Ferman TJ; Jones DT; Savica R; Knopman DS; Petersen RC; Jack CR; Kantarci K
Neuroimage Clin; 2018; 19():939-947. PubMed ID: 30003031
[TBL] [Abstract][Full Text] [Related]
2.
Whitwell JL; Graff-Radford J; Singh TD; Drubach DA; Senjem ML; Spychalla AJ; Tosakulwong N; Lowe VJ; Josephs KA
J Nucl Med; 2017 Apr; 58(4):632-638. PubMed ID: 27688479
[TBL] [Abstract][Full Text] [Related]
3. Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.
Iizuka T; Kameyama M
Ann Nucl Med; 2016 Jul; 30(6):421-9. PubMed ID: 27098829
[TBL] [Abstract][Full Text] [Related]
4. Brain
Woyk K; Sahlmann CO; Hansen N; Timäus C; Müller SJ; Khadhraoui E; Wiltfang J; Lange C; Bouter C
J Neuroimaging; 2023 Mar; 33(2):256-268. PubMed ID: 36465027
[TBL] [Abstract][Full Text] [Related]
5. Amygdala sign, a FDG-PET signature of dementia with Lewy Bodies.
Pillai JA; Wu G; Tousi B; Larvie M; Léger GC; Leverenz JB
Parkinsonism Relat Disord; 2019 Jul; 64():300-303. PubMed ID: 30905401
[TBL] [Abstract][Full Text] [Related]
6. AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies.
Kantarci K; Lowe VJ; Boeve BF; Senjem ML; Tosakulwong N; Lesnick TG; Spychalla AJ; Gunter JL; Fields JA; Graff-Radford J; Ferman TJ; Jones DT; Murray ME; Knopman DS; Jack CR; Petersen RC
Ann Neurol; 2017 Jan; 81(1):58-67. PubMed ID: 27863444
[TBL] [Abstract][Full Text] [Related]
7. Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG-PET in Early-Onset Alzheimer's Disease.
Verclytte S; Lopes R; Lenfant P; Rollin A; Semah F; Leclerc X; Pasquier F; Delmaire C
J Neuroimaging; 2016; 26(2):207-12. PubMed ID: 26031943
[TBL] [Abstract][Full Text] [Related]
8. The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.
Lim SM; Katsifis A; Villemagne VL; Best R; Jones G; Saling M; Bradshaw J; Merory J; Woodward M; Hopwood M; Rowe CC
J Nucl Med; 2009 Oct; 50(10):1638-45. PubMed ID: 19759102
[TBL] [Abstract][Full Text] [Related]
9. Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria.
Caminiti SP; Sala A; Iaccarino L; Beretta L; Pilotto A; Gianolli L; Iannaccone S; Magnani G; Padovani A; Ferini-Strambi L; Perani D
Alzheimers Res Ther; 2019 Feb; 11(1):20. PubMed ID: 30797240
[TBL] [Abstract][Full Text] [Related]
10. Differential Effects of Tau Stage, Lewy Body Pathology, and Substantia Nigra Degeneration on
Silva-Rodríguez J; Labrador-Espinosa MA; Moscoso A; Schöll M; Mir P; Grothe MJ;
J Nucl Med; 2023 Feb; 64(2):274-280. PubMed ID: 36008119
[TBL] [Abstract][Full Text] [Related]
11. Arterial spin labeling versus
Dolui S; Li Z; Nasrallah IM; Detre JA; Wolk DA
Neuroimage Clin; 2020; 25():102146. PubMed ID: 31931403
[TBL] [Abstract][Full Text] [Related]
12. A visual rating scale for cingulate island sign on 18F-FDG-PET to differentiate dementia with Lewy bodies and Alzheimer's disease.
Gjerum L; Frederiksen KS; Henriksen OM; Law I; Anderberg L; Andersen BB; Bjerregaard E; Hejl AM; Høgh P; Hasselbalch SG
J Neurol Sci; 2020 Mar; 410():116645. PubMed ID: 31911283
[TBL] [Abstract][Full Text] [Related]
13. FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD.
Kantarci K; Boeve BF; Przybelski SA; Lesnick TG; Chen Q; Fields J; Schwarz CG; Senjem ML; Gunte JL; Jack CR; Min P; Jain M; Miyagawa T; Savica R; Graff-Radford J; Botha H; Jones DT; Knopman DS; Graff-Radford N; Ferman TJ; Petersen RC; Lowe VJ
Neuroimage Clin; 2021; 31():102754. PubMed ID: 34252877
[TBL] [Abstract][Full Text] [Related]
14. Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.
Gomperts SN; Locascio JJ; Makaretz SJ; Schultz A; Caso C; Vasdev N; Sperling R; Growdon JH; Dickerson BC; Johnson K
JAMA Neurol; 2016 Nov; 73(11):1334-1341. PubMed ID: 27654968
[TBL] [Abstract][Full Text] [Related]
15. Dementia with Lewy bodies: basis of cingulate island sign.
Graff-Radford J; Murray ME; Lowe VJ; Boeve BF; Ferman TJ; Przybelski SA; Lesnick TG; Senjem ML; Gunter JL; Smith GE; Knopman DS; Jack CR; Dickson DW; Petersen RC; Kantarci K
Neurology; 2014 Aug; 83(9):801-9. PubMed ID: 25056580
[TBL] [Abstract][Full Text] [Related]
16. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.
Spehl TS; Hellwig S; Amtage F; Weiller C; Bormann T; Weber WA; Hüll M; Meyer PT; Frings L
J Neuroimaging; 2015; 25(2):281-288. PubMed ID: 24593796
[TBL] [Abstract][Full Text] [Related]
17. The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies.
Chiba Y; Fujishiro H; Iseki E; Kasanuki K; Sato K
J Neuroimaging; 2019 Nov; 29(6):712-720. PubMed ID: 31199036
[TBL] [Abstract][Full Text] [Related]
18. Spatial metabolic profiles to discriminate dementia with Lewy bodies from Alzheimer disease.
Iizuka T; Kameyama M
J Neurol; 2020 Jul; 267(7):1960-1969. PubMed ID: 32170446
[TBL] [Abstract][Full Text] [Related]
19. Brain perfusion in dementia with Lewy bodies and Alzheimer's disease: an arterial spin labeling MRI study on prodromal and mild dementia stages.
Roquet D; Sourty M; Botzung A; Armspach JP; Blanc F
Alzheimers Res Ther; 2016 Jul; 8():29. PubMed ID: 27401267
[TBL] [Abstract][Full Text] [Related]
20. Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism.
Chiba Y; Fujishiro H; Ota K; Kasanuki K; Arai H; Hirayasu Y; Sato K; Iseki E
Int J Geriatr Psychiatry; 2015 Mar; 30(3):316-23. PubMed ID: 24839913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
